The Series C financing was led by Leaps by Bayer and Hitachi Ventures to support international expansion and platform development.
"This is a pivotal moment in Huma’s development. We have exceptional partners and strategic investors who will support us in our mission to help people worldwide live longer and fuller lives. We’re already demonstrating how ‘hospital at home’ can transform healthcare, and how decentralized clinical trials can advance research in ways that weren’t imaginable even one year ago. Now we want to accelerate the pace of change and continue to innovate for better care and research worldwide."
The grant will support the development of the CUOREMA project with international collaborators.
"We are thrilled to be partnering with such talented and diverse teams on this innovative and important project over the next few years. Each organisation brings a very unique perspective to the table, allowing for a thoughtful and comprehensive approach to tackling heart health. I am extremely passionate about digital health and this has the potential to change many lives for the better, helping us transform cardiac rehabilitation for patients across Europe."
The funding round was led by Technology Venture Partners alongside government backing to support the commercialisation of a new breast scanning system.
"this investment will allow us to move the company into the next phase with a system that has a place in a clinical workflow and more exciting functionality to come as soon as clinical data collection can re commence"
KEEN Venture Partners led the Series A follow-on round, with backing from existing investors and Tom Teichman.
"Doctify co-founders Stephanie and Suman, both surgeons by background, bring deep expertise in healthcare and are in prime position to transform and win the market. Their solution is driving real-time improvements to patient care across multiple international providers."
